Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...